Effects of Sphingosine 1-Phosphate Lyase Deficiency on Immune Function in Mice
Author Information
Author(s): Peter Vogel, Michael S. Donoviel, Robert Read, Gwenn M. Hazlewood, Jill Anderson, Stephen J. Sun, Weimei Swaffield, Jonathan Oravecz, Tamas Alberola-Ila
Primary Institution: Lexicon Pharmaceuticals, Inc.
Hypothesis
What are the effects of varying levels of Sphingosine 1-Phosphate Lyase (S1PL) activity on immune system function and non-lymphoid lesions in mice?
Conclusion
Partial inhibition of S1PL can lead to therapeutic immunosuppression without causing significant lesions in non-lymphoid organs.
Supporting Evidence
- All S1PL-deficient genetic models displayed lymphopenia and significant lesions in various organs.
- Partial restoration of S1PL activity in humanized mice prevented lethal non-lymphoid lesions.
- S1PL−/− mice had a markedly reduced life span, with all dying by 15 weeks of age.
- Complete absence of S1PL affected T-cell maturation and egress from the thymus.
- Low levels of S1PL activity were sufficient to protect against severe non-lymphoid lesions.
Takeaway
This study found that a lack of a specific enzyme in mice affects their immune system and can lead to serious health problems, but having just a little bit of that enzyme can help keep them healthy.
Methodology
The study used knockout and humanized mouse models to assess the effects of S1PL activity on immune function and pathology.
Potential Biases
Potential bias due to the use of genetically modified mice and the specific focus on S1PL activity.
Limitations
The study primarily focused on mouse models, which may not fully replicate human responses.
Participant Demographics
Mice of mixed genetic background (129S5/SvEvBrd and C57BL/6J).
Statistical Information
P-Value
3×10−7
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website